Literature DB >> 29567823

Cervical Cancer in Ethiopia: The Effect of Adherence to Radiotherapy on Survival.

Ulrike Moelle1, Assefa Mathewos2, Abreha Aynalem2, Tigeneh Wondemagegnehu2, Bekuretsion Yonas2, Matthias Begoihn1, Adamu Addissie2, Susanne Unverzagt1, Ahmedin Jemal3, Christoph Thomssen1, Dirk Vordermark1, Eva J Kantelhardt4.   

Abstract

BACKGROUND: Discontinuation of radiotherapy (RT) for cervical cancer (CC) in sub-Saharan Africa is common because of patient- and health service-related reasons. This analysis describes toxicities and the effect of adherence on survival.
MATERIALS AND METHODS: A total of 788 patients with CC (2008-2012) who received RT at Addis Ababa University Hospital were included. External beam RT without brachytherapy was performed according to local guidelines. We previously described survival and prognostic factors. Now we analyzed adherence and survival according to total doses received. Adjustment via multivariate cox regression analysis was done.
RESULTS: One-year overall survival (OS) after radical RT (n = 180) for International Federation of Gynecology and Obstetrics (FIGO) stages IIA-IIIA was 89% for discontinuation (<72 Gy) and 96% for adherence (≥72 Gy; hazard ratio [HR], 1.3; 95% confidence interval [CI], 0.5-3.3). One-year OS after nonradical RT (n = 389) for FIGO stages IIIB-IVA was 71% for discontinuation (<40 Gy) and 87% for adherence (44-50 Gy; HR, 3.1; 95% CI, 1.4-6.9). One-year OS for FIGO stages IIIB-IVB (n = 219) after one compared with two or more palliative single fractions of 10 Gy were 14% and 73% respectively (HR, 7.3; 95% CI, 3.3-16). Reasons for discontinuation were toxicities, economic background, and RT machine breakdown. Grade 1-2 late toxicities were common (e.g., 30% proctitis, 22% incontinence). Grade 3 early and late toxicities were seen in 5% and 10% respectively; no grade 4 toxicities occurred.
CONCLUSION: Patients who adhered to guideline-conforming RT had optimum survival. Better supportive care, brachytherapy to reduce toxicities, socioeconomic support, and additional radiation capacities could contribute to better adherence and survival. IMPLICATIONS FOR PRACTICE: This study presents the effect of adherence on survival of 788 patients with cervical cancer receiving external beam radiotherapy without brachytherapy in Ethiopia. Discontinuation of planned radiotherapy according to local guidelines considerably reduced survival for all International Federation of Gynecology and Obstetrics (FIGO) stages treated (hazard ratios were 1.3, 3.1, and 7.3 for FIGO stages IIA-IIIA and IIIB-IVA and the palliative approach, respectively). Early toxicity (5% grade 3) should be treated to improve adherence. Economic difficulties and machine breakdown should also be addressed to reduce discontinuation and improve survival. © AlphaMed Press 2018.

Entities:  

Keywords:  Adherence; Cervical cancer; Radiotherapy; Sub‐Saharan Africa; Survival

Mesh:

Year:  2018        PMID: 29567823      PMCID: PMC6192604          DOI: 10.1634/theoncologist.2017-0271

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  32 in total

Review 1.  Palliative radiation therapy for gynaecological malignancies.

Authors:  S C Smith; W J Koh
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2001-04       Impact factor: 5.237

Review 2.  Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule?

Authors:  D G Petereit; R Pearcey
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-15       Impact factor: 7.038

3.  Revised FIGO staging for carcinoma of the cervix.

Authors:  Sergio Pecorelli; Lucia Zigliani; Franco Odicino
Journal:  Int J Gynaecol Obstet       Date:  2009-04-01       Impact factor: 3.561

4.  Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy.

Authors:  Eva Johanna Kantelhardt; Ulrike Moelle; Matthias Begoihn; Adamu Addissie; Pietro Trocchi; Bekuretsion Yonas; Petros Hezkiel; Andreas Stang; Christoph Thomssen; Dirk Vordermark; Tufa Gemechu; Yirgu Gebrehiwot; Tigeneh Wondemagegnehu; Abreha Aynalem; Assefa Mathewos
Journal:  Oncologist       Date:  2014-06-20

5.  Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables.

Authors:  Robson Ferrigno; Sérgio Luis Campos de Oliveira Faria; Eduardo Weltman; João Victor Salvajoli; Roberto Araújo Segreto; Ayrton Pastore; Wladimir Nadalin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

6.  Survival of cervix cancer patients in Harare, Zimbabwe, 1995-1997.

Authors:  Eric Chokunonga; Agnihotram V Ramanakumar; Anna M Nyakabau; Margaret Z Borok; Z Michael Chirenje; Risto Sankila; D Maxwell Parkin
Journal:  Int J Cancer       Date:  2004-03-20       Impact factor: 7.396

7.  Radiation therapy interruption in a poor resource setting: causes and management..

Authors:  B I Akinlade; A M Folasire; T N Elumelu-Kupoluyi; A A Adenipekun; U B Iyobosa; O B Campbell
Journal:  Afr J Med Med Sci       Date:  2014-12

8.  Carcinoma of the uterine cervix treated with external irradiation alone.

Authors:  Y Akine; I Hashida; Y Kajiura; K Watai; I Tsukiyama; S Egawa; T Yamada; K Tanemura; R Tsunematsu; K Ohmi
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-09       Impact factor: 7.038

9.  Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study.

Authors:  Alemayehu Hailu; Damen Haile Mariam
Journal:  BMC Cancer       Date:  2013-02-08       Impact factor: 4.430

10.  Survival of cervix cancer patients in Kampala, Uganda: 1995-1997.

Authors:  H Wabinga; A V Ramanakumar; C Banura; A Luwaga; S Nambooze; D M Parkin
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

View more
  12 in total

1.  Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study.

Authors:  Andamlak Eskale Mebratie; Nurilign Abebe Moges; Belsity Temesgen Meselu; Misganaw Fikrie Melesse
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

2.  Designing Dihydrofolate Reductase Inhibitors as X-ray Radiosensitizers to Reverse Radioresistance of Cervical Cancer.

Authors:  Yuanwei Liang; Delong Zeng; Yuanyuan You; Bin Ma; Xiaoling Li; Tianfeng Chen
Journal:  ACS Med Chem Lett       Date:  2020-06-17       Impact factor: 4.345

3.  Identification of differentially expressed genes in cervical cancer by bioinformatics analysis.

Authors:  Yanshan Ge; Chaoyang Zhang; Songshu Xiao; Lin Liang; Shan Liao; Yanqi Xiang; Ke Cao; Hongxiang Chen; Yanhong Zhou
Journal:  Oncol Lett       Date:  2018-06-12       Impact factor: 2.967

4.  Cervical Cancer in Sub-Saharan Africa: A Multinational Population-Based Cohort Study of Care and Guideline Adherence.

Authors:  Mirko Griesel; Tobias P Seraphin; Nikolaus C S Mezger; Lucia Hämmerl; Jana Feuchtner; Walburga Yvonne Joko-Fru; Mazvita Sengayi-Muchengeti; Biying Liu; Samukeliso Vuma; Anne Korir; Gladys C Chesumbai; Sarah Nambooze; Cesaltina F Lorenzoni; Marie-Thérèse Akele-Akpo; Amalado Ayemou; Cheick B Traoré; Tigeneh Wondemagegnehu; Andreas Wienke; Christoph Thomssen; Donald M Parkin; Ahmedin Jemal; Eva J Kantelhardt
Journal:  Oncologist       Date:  2021-03-10

5.  Cervical cancer in Ethiopia - predictors of advanced stage and prolonged time to diagnosis.

Authors:  Matthias Begoihn; Assefa Mathewos; Abreha Aynalem; Tigeneh Wondemagegnehu; Ulrike Moelle; Muluken Gizaw; Andreas Wienke; Christoph Thomssen; Dawit Worku; Adamu Addissie; Ahmedin Jemal; Eva Johanna Kantelhardt
Journal:  Infect Agent Cancer       Date:  2019-11-11       Impact factor: 2.965

6.  Survival status and associated factors of death among cervical cancer patients attending at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective cohort study.

Authors:  Mulugeta Wassie; Zeleke Argaw; Yosief Tsige; Mesfin Abebe; Sezer Kisa
Journal:  BMC Cancer       Date:  2019-12-16       Impact factor: 4.430

7.  Efficacy and Safety of Image-Guided Intensity-Modulated Radiation Therapy and Volumetric Modulated Arc Therapy Combined with Paclitaxel Liposomes and Cisplatin for Locally Advanced Stage IIB-IIIB Cervical Cancer: A Retrospective Study at a Single Center.

Authors:  Meihua Xie; Xiuxiu Ding; Aiyu Chen; Huiqin Xiao; Xiaoye Wang; Youhong Wang; Huan Zhang
Journal:  Med Sci Monit       Date:  2020-12-09

8.  Contemporary treatment patterns and survival of cervical cancer patients in Ethiopia.

Authors:  Biniyam Tefera Deressa; Mathewos Assefa; Ephrem Tafesse; Eva Johanna Kantelhardt; Ivan Soldatovic; Nikola Cihoric; Daniel Rauch; Ahmedin Jemal
Journal:  BMC Cancer       Date:  2021-10-13       Impact factor: 4.430

9.  Patterns of Care of Cancers and Radiotherapy in Ethiopia.

Authors:  Tara Rick; Biruk Habtamu; Wondemagegnhu Tigeneh; Aynalem Abreha; Yvette van Norden; Surbhi Grover; Mathewos Assefa; Luca Incrocci
Journal:  J Glob Oncol       Date:  2019-11

10.  Efficacy of preoperative brachytherapy for controlling vaginal bleeding in early-stage cervical cancer: a retrospective study.

Authors:  Quanhong Ping; Jing Zeng; Peisong Sun; Pengpeng Qu; Shan Jiang; Yuanjing Hu
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.